Cecelia Brewer
Family · Amarillo, TXNPI 1578998951
Payments from drug & device makers
Across 236 payments — averaging $19.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$941
- Lilly USA, LLC$713
- Novo Nordisk$399
- Corcept Therapeutics$392
- Sanofi-aventis U.S. LLC$326
- Recordati_rare_diseases_inc.$188
- plus $2K from 20 others
What the payments were for
- Food & beverage$4,573100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 41 | $941 |
| Lilly USA, LLC | 46 | $713 |
| Novo Nordisk | 18 | $399 |
| Corcept Therapeutics | 19 | $392 |
| Sanofi-aventis U.S. LLC | 14 | $326 |
| Recordati_rare_diseases_inc. | 9 | $188 |
| Amgen(2 entities) | 6 | $180 |
| Dexcom, Inc. | 11 | $166 |
| Bayer | 8 | $151 |
| Boehringer Ingelheim | 8 | $135 |
| Medtronic | 8 | $134 |
| Xeris Pharmaceuticals, Inc. | 5 | $93 |
| Tandem Diabetes Care, Inc. | 4 | $88 |
| Amryt Pharma Holdings Ltd | 4 | $76 |
| EUSA Pharma (US) LLC | 5 | $75 |
| Novartis | 4 | $71 |
| Merck | 5 | $67 |
| Esperion Therapeutics, Inc. | 3 | $60 |
| Radius Health, Inc. | 3 | $54 |
| Amarin Pharma, Inc. | 4 | $52 |
| Chiesi USA, Inc. | 2 | $50 |
| IBSA Pharma Inc. | 3 | $44 |
| Antares Pharma, Inc. | 1 | $42 |
| Insulet Corporation | 2 | $33 |
| BETA Bionics, Inc. | 2 | $24 |
| Kyowa Kirin, Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FREESTYLE LIBRE 3$266
- Saxenda$105
How this compares
$4,573 in reported general payments places this provider in the 90th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 59 | $66,449 |
| MounjaroTirzepatide | 52 | $59,944 |
| OzempicSemaglutide | 28 | $40,345 |
| FarxigaDapagliflozin Propanediol | 18 | $11,453 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 15 | $10,182 |
| Novolog FlexpenInsulin Aspart | 17 | $9,201 |
| Tresiba Flextouch U-100Insulin Degludec | 12 | $7,341 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 26 | $7,150 |
| Hydrocortisone | 47 | $3,867 |
| Levothyroxine Sodium | 290 | $1,849 |
| SynthroidLevothyroxine Sodium | 27 | $1,100 |
| Gabapentin | 32 | $990 |
| Metformin Hcl | 67 | $861 |
| Atorvastatin Calcium | 53 | $483 |
| Ezetimibe | 14 | $446 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $135 | $66,44959 claims |
| Lilly USA, LLCMounjaro | $713 | $59,94452 claims |
| Novo NordiskOzempic | $399 | $40,34528 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 15,456 family providers in Texas.
Other family in Amarillo
- Kyla BeedyAmarillo$54K
- Tiffany RandleAmarillo$50K
- Cory PickettAmarillo$34K
- Lashonda CraneHouston$3.4M
- David WeirDallas$959K
- Luba YammineHouston$479K
- Robin BeachHouston$428K
- Nirupama JeromeAustin$418K
- April LopezMcAllen$417K
- Linda MercadoHouston$211K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.